Condition (MeSH)
Tinea Versicolor
ClinicalTrials.gov lists 16 trials for Tinea Versicolor or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
16 of the 16 trials are tagged with Tinea Versicolor itself; the rest are tagged with a narrower condition beneath it.
When did Tinea Versicolor trials start? (9)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 4
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 2 |
| 2023 | 2 |
| 2022 | 1 |
| 2021 | 2 |
| 2020 | 1 |
| 2019 | 1 |
| 2018 | 3 |
| 2008 | 1 |
No forecast is made for this condition: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Tinea Versicolor trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 3 |
| Phase 1/2 | 1 |
| Phase 2 | 3 |
| Phase 4 | 6 |
| Observational | 3 |
How many Tinea Versicolor trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 2 |
| Completed | 9 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Tinea Versicolor trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| DermBiont, Inc. | 1 |
| Jinnah Postgraduate Medical Centre | 1 |
| Sun Pharmaceutical Industries, Inc. | 1 |
Which drugs are being tested for Tinea Versicolor? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Itraconazole | 3 |
Interventions as named in the registry (14)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Fluconazol | 2 |
| Topical ketoconazole 2% cream | 1 |
| Ketoconazole Shampoo, 2% | 1 |
| 20% Cassia alata cream | 1 |
| Topical 1 % clotrimazole twice daily 2 weeks | 1 |
Showing 5 of 14 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Tinea Versicolor? (12)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Factors associated with pityriasis versicolor in a large national database. | Mycoses | 2024 | Yes |
| Malassezia virulence factors and their role in dermatological disorders. | Acta dermatovenerologica Alpina, Pannonica, et Adriatica | 2022 | Yes |
| Efficacy and tolerability of a spray product containing hydroxypropyl chitosan, climbazole and piroctone olamine, applied twice weekly for the treatment of the pitiriasis versicolor. | Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia | 2017 | Yes |
| Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases. | Acta dermato-venereologica | 2015 | Yes |
| Tinea versicolor in dark-skinned individuals. | International journal of dermatology | 2014 | Yes |
Showing 5 of 12 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.